Skip to main content

Find Clinical Trials

Home
Conditions
Lymphoma, B-Cell

Clinical trial condition

Lymphoma, B-Cell

Explore clinical trials studying Lymphoma, B-Cell. Study availability and eligibility vary by location and protocol.

503 public trials 139 recruiting studies

Refine in advanced search Browse all conditions

Lymphoma, B-Cell trial results

Recruiting

Chidamide Combined With Linperlisibon for the Treatment of Refractory/Relapsed Follicular Lymphoma

NCT06158386

Conditions: Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations: Bing Xu Xiamen, Fujian, China

View Trial Details

Recruiting

CAR2219 CAR-T Cells for the Treatment of R/R B Cell Leukemia and Lymphoma

NCT06834529

Conditions: Disease Attributes, Hematologic Diseases, Hemic and Lymphatic Diseases, +16 more
Locations: the Fifth Medical Center of Chinese People's Liberation Army General Hospital Beijing, Beijing Municipality, China

View Trial Details

Recruiting

A Clinical Study Exploring CT1190B in the Treatment of Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma

NCT06822868

Conditions: B-Cell Non-Hodgkin Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations: Beijing GoBroad Hospital Beijing, Beijing Municipality, China

View Trial Details

Recruiting

Immunotherapy in Lymphoma

NCT06796517

Conditions: Burkitt Lymphoma, DNA Virus Infections, Diffuse Large B Cell Lymphoma Relapsed, +22 more
Locations: Seoul St. Mary Hospital Seoul, South Korea

Yeoido St. Mary Hospital Seoul, South Korea

View Trial Details

Recruiting

Phase Ib Clinical Study of Keynatinib

NCT04807881

Conditions: Chronic Disease, Disease Attributes, Hematologic Diseases, +18 more
Locations: Cancer Hospital, Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China

Peking University Third Hospital Beijing, Beijing Municipality, China

Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China

West China Hospital，Sichuan University Chengdu, Sichuan, China

View Trial Details

Recruiting

Local Manufacture of CAR T-Cell Products for the Treatment of B-Cell Lymphoma and B-Acute Lymphoblastic Leukemia

NCT05281809

Conditions: B Acute Lymphoblastic Leukemia, B-cell Lymphoma, Burkitt Lymphoma, +36 more
Locations: AHN Cancer Institute - West Penn Hospital Pittsburgh, Pennsylvania, United States

View Trial Details

Recruiting

Safety and Efficacy of Fourth-Generation CAR-T in the Treatment of Hematologic Malignancies

NCT06758713

Conditions: B-cell Lymphoma, Blood Protein Disorders, Cardiovascular Diseases, +20 more
Locations: The Third Affiliated Hospital of Southern Medical University Guangzhou, Guangdong, China

View Trial Details

Recruiting

A Clinical Study Exploring CT1190B in the Treatment of Patients with Relapsed/refractory B-cell Non-Hodgkin Lymphoma

NCT06734871

Conditions: B-Cell Non-Hodgkin Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations: Shanghai Tongji Hospital Shanghai, Shanghai Municipality, China

View Trial Details

Recruiting

A Study of JMT601 in Participants With Relapsed or Refractory CD20-positive B-cell Non-Hodgkin Lymphoma

NCT06725524

Conditions: B-cell Non Hodgkin Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations: Ruijin Hospital Shanghai, China

View Trial Details

Recruiting

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

NCT05476770

Conditions: ALL, AML, Acute Undifferentiated Leukemia, +30 more
Locations: Children's Hospital Los Angeles Los Angeles, California, United States

Children's Hospital Orange County Orange, California, United States

UCSF School of Medicine San Francisco, California, United States

Children's Hospital Colorado Denver, Colorado, United States

View all 31 locations

View Trial Details